This bioreactor was developed to study the individual and combined effects of shear stress and cyclic stretch on vascular tissue growth and remodeling in 3D biomaterial scaffolds. The design of the bioreactor allows for culturing up to eight vascular constructs under various loading conditions (Figure 1A). The vascular constructs are positioned in a flow culture chamber (Figure 1B) in which both the circumferential stretch and WSS can be independently controlled. The top compartment of the flow culture chamber holds a flow straightener to stabilize the flow in a relatively short settling length (Figure 1C). Directly downstream of the flow straightener, the nose cone distributes the flow evenly through the annular channel (Figure 1D). When all steps of the protocol are performed in the correct manner, the vascular scaffolds in the flow culture chamber can be subjected to a continuous unidirectional flow through the annular channel between the scaffold and the glass wall and are circumferentially stretched by the pneumatic pump (Figure 1E–F). Before the scaffold is mounted, the electrospun tube should be cut into 25 mm tubes (Figure 1G) and can be examined with SEM to analyze the microarchitecture (Figure 1H–I). It is important to note that the PCL-BU grafts in this example can be replaced by any other elastomeric tissue engineered grafts (natural or synthetic origin, different microarchitecture or porosity). The inside-out design allows testing of highly porous grafts as it does not necessarily have to be leak-free. The schematic image of the flow culture chamber shows the physical interpretation of the parameters used in the equations to describe the WSS (equation 1), the pressure gradient (equation 2), and the circumferential stretch (equation 3) (Figure 1J).
Incorrect execution of the critical steps of the protocol can result in a few scenarios. For example, leakage from the hydraulic reservoir can occur as a result of incorrectly mounted knots, leading to leakage of hydraulic fluid from the pressure conduits with holes passing the silicone tube and entering the flow culture chamber (Figure 2A). Leakage of the hydraulic fluid at the connection between the screw threads and the bioreactor base can also occur when the silicone ring is not well placed or if the Teflon bellow was not allowed to slightly expand O/N one day before the experiment (Figure 2B). Furthermore, when medium is not degassed, or if the medium levels in the medium reservoirs are not well balanced and one medium reservoir runs dry, resulting in air being sucked into the system, air bubbles can arise in the flow culture chamber (Figure 2C), which disturbs the WSS patters, compromising cell viability and subsequent tissue growth. Lastly, when the silicone O-ring in the bottom compartment is not correctly placed, medium spill may be observed below the flow culture chamber (Figure 2D).
As this bioreactor setup allows for the application of individual and combined hemodynamic loads, multiple hemodynamically loaded experimental groups can be included in one experiment (Figure 3A). Previously, different hemodynamic loads (i.e., two shear stress regimes and two stretch regimes) were validated by applying various possible system settings (Figure 3B). When stretch (Figure 3C) and WSS (Figure 3D) were monitored over long-term culture periods, it was validated that these can be maintained at relatively constant levels over a period of up to 20 days.
The bioreactor is especially well suited to study the influence of hemodynamic loading on growth and remodeling in an in situ vascular TE context. The stages of in situ TE are hypothesized to mirror the stages of the natural wound healing response (Figure 4A). The co-cultures of monocyte-derived macrophages and myofibroblasts derived from human saphenous veins, as described here, were established as an in vitro mimic of the proliferative phase. Three days after seeding, immunofluorescence staining showed a homogenous distribution of both cell types throughout the scaffold (Figure 4B). After 20 days of co-culture, cyclic stretch alone resulted in the deposition of more numerous and thicker collagen type I fibers, while in the group with combined hemodynamic loads, this effect of cyclic stretch was overruled by shear stress, resulting in less pronounced collagen type I deposition, illustrated here by immunofluorescence staining (Figure 4C). For successful in situ tissue regeneration, a tight balance between tissue production and scaffold resorption is required. In addition to tissue formation, the bioreactor allows for the induction of cell-driven scaffold resorption. For example, when culturing a mono-culture of macrophages for 8 days on the electrospun grafts, fiber erosion and fiber cleavage were observed in all hemodynamic loading regimes, with the most pronounced resorption in the static group and least pronounced resorption in the shear stress group (Figure 4D). Together, these results show the impact of the different hemodynamic loading regimes on both growth and remodeling. These insights are helpful in optimizing the design parameters for newly developed in situ TEVGs.
Another important determinant of the tissue regeneration process is the presence of pro- and anti-inflammatory cytokines. As the bioreactor is a closed-loop system, the cells in the system will be continuously exposed to the paracrine stimuli of secreted factors. The cytokine secretion profiles in the medium of the dynamically loaded co-cultures of human peripheral blood mononuclear cell (PBMC)-derived macrophages and human myofibroblasts from saphenous veins were analyzed in early and later stages (Figure 5A). These representative results illustrate the impact of both cyclic stretch and shear stress on the cytokine secretion profile in the co-culture setup. Interestingly, the combined effects of both loads showed either dominance of one of the two loads (e.g., cyclic stretch for interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1)) or synergistic effects of both loads (e.g., for IL-10) (Figure 5B). These insights, gathered by using this in vitro testing platform, give valuable information for the development of in situ TEVGs that are based on the rationale of macrophage-driven in situ tissue regeneration.
Co-culture experiments of macrophages and myofibroblast showed that the mechanical environment and the resulting loading-dependent inflammatory environments modulated the phenotype of the myofibroblasts. After 20 days of hemodynamic loading, gene expression of myofibroblast markers showed clear differences in the individual and combined impact of the loading and in direct and paracrine signaling of macrophages on myofibroblasts (Figure 6A). Furthermore, the gene expression patterns of contractile marker alpha smooth muscle actin correlated with protein synthesis (Figure 6B). Furthermore, cyclic stretch stimulated collagenous and elastic matrix gene expression and attenuated matrix metalloproteinase 1/tissue inhibitor matrix metalloproteinase 1-mediated collagen remodeling, whereas a stabilizing effect of shear stress was observed in the co-culture (Figure 6C). These long-term co-culture experiments show the possibility of studying the later stage tissue remodeling phase (Figure 4A) in various hemodynamic loading regimes in tissue engineered vascular grafts with this bioreactor. As the TEVG are mounted “inside out” on a silicone tube, the circular stretch and WSS can be applied for longer culture periods.

Figure 1: Design and overview of the bioreactor. (A) Construction drawing of the bioreactor base and (B) exploded view of the fluid culture chamber with all parts indicated (steps 2.4–2.8). The top compartment of the flow culture chamber holds a flow straightener. (C) The spherically blunted nose cone is positioned after the flow straightener to distribute the flow through the annular channel (flow direction indicated in pink). (D) Together, these components control and guide flow directionality. See Table 1 for a functional description of the individually mentioned parts. (E) Photograph of complete bioreactor setup (step 5.2) and (F) a close-up view of the flow culture chambers and pneumatic cylinder (step 5.6.1). (G) Gross appearance of the electrospun PCL-BU scaffold before seeding (ruler ticks 1 mm). Scanning electron microscopic images of tubular electrospun PCL-BU scaffold with 3 mm inner diameter and 5 µm average fiber diameter at different magnifications, scale bars (H) 100 µm and (I) 10 µm (step 1.3). (J) Schematic image of the culture chamber consisting of a tubular electrospun scaffold, with outer radius (r1) centered in a glass tube of inner radius (r2). The flow (Q) inlets and outlets are connected to the annular ring, with channel height h for applying wall shear stress (t). The pressure/stretch (P) inlet is connected to the silicone-mounted scaffold for applying a circumferential stretch (λ(t)) to the mounted electrospun scaffolds from the inside (step 6.1). Abbreviations: polycaprolactone bisurea (PCL-BU). Panels C, D and G–J were adapted from Van Haaften et al.19. Please click here to view a larger version of this figure.
| Bioreactor parts | Functional description |
| Stretch application |
| Pneumatic cylinder | Actuates Teflon bellow. |
| Teflon bellow | Loads the hydraulic reservoir. |
| Hydraulic reservoir | Can be connected with up to 8 flow culture chambers, is filled with demi water, applies pressure to the silicone mounted constructs. |
| Screw thread | Connection between the flow culture chamber and hydraulic reservoir. The pressure inlet for the silicone mounted constructs. |
| White luer connector | Used to screw the flow culture chamber tight to one of the eight screw threads on the hydraulic reservoir/bioreactor base. |
| Pressure conduit with small holes | Directly connected with water in hydraulic reservoir. When the hydraulic reservoir is pressurized, the pressure conduits fill the space in between the silicone tube (that is mounted on the pressure conduit) with water, pushing the silicone tubing outwards, resulting in a circumferential stretch on the silicone mounted graft from inside. |
| Silicone tubing | To mount the electrospun graft on the pressure conduit. The silicone tubing is circumferentially stretched from inside. |
| Flow application |
| Flow pump system | Used to control the flow in the flow culture chambers. (in our example: an ibidi pump system is used.) |
| Top and bottom compartment with flow inlet and outlet | Connects the flow culture chamber into the flow loop. |
| Glass tube | Contains the pressurized scaffold in the center and allows perfusion of the scaffolds. |
| Flow straightener | Stabilizes the flow in a relatively short settling length. |
| Nose cone | Distributes the flow evenly. |
| Adapter bushing | Fixes the glass tube. |
| Silicone O-ring | Prevents leakage of medium. |
Table 1: Functional description of bioreactor main features, corresponds with indicated parts in Figure 1A-D.

Figure 2: Results of inaccurate execution of the critical steps in the protocol. Photographs of some occurrences that can be observed in the bioreactor setup when critical steps are not performed in the correct manner. (A) If the knot is not tight enough or not exactly placed in the engraved groove (indicated by arrow), a slight leakage of hydraulic fluid into the flow culture chamber may occur (step 2.5). (B) If the Teflon bellow was not allowed to expand O/N one day before the experiment or when the silicone ring is not well placed, hydraulic liquid leakage from the hydraulic liquid at the connection between the screw threads and the bioreactor base might occur (indicated by arrow) (step 1.4 and 5.2.3). (C) Air bubbles in the flow culture chamber (indicated by arrow) will result in disturbed shear stress patterns. Always degas the culture medium and make sure that the medium levels in the medium reservoirs are balanced to prevent one reservoir running dry and air getting sucked into the flow chamber system (steps 1.2 and 5.5.4). (D) When the silicone ring in the bottom compartment is not placed correctly, spillage of the medium may be observed (indicated by arrow) (step 2.4.2). Please click here to view a larger version of this figure.

Figure 3: Control of shear stress and stretch. As the bioreactor allows for independent and combined application of stretch and shear, (A) multiple experimental groups can be included in one experiment. (B) Examples of variations in maximum stretches and shear stresses at a specific point in time tested under four distinct system settings (indicated by the colors). Black rectangles represent mean ± standard deviation of the measurements for each setting. The dotted lines are computed as the mean of the stretches (horizontal line) and the shear stresses (vertical line) to indicate the four distinct loading conditions. (C) Cyclic circumferential stretches in the cyclic stretch and combined groups over the course of the experiment of 20 days, based on outer diameter measurements of the scaffold constructs monitored with a time lapse of high-speed camera (step 6.2). (D) Monitored wall shear stresses in the shear stress and combined groups over the course of the experiment, based on the changing medium levels in the syringe (step 6.1). Panels A, C, and D were adapted from Van Haaften and Wissing et al.44; panel B was adapted from Van Haaften et al.19. Please click here to view a larger version of this figure.

Figure 4: Concept of in situ vascular tissue engineering, cell distribution, tissue production, and scaffold degradation. (A) A schematic illustration depicting the hypothesized phases of scaffold-driven tissue regeneration at the host’s functional site. The results shown are derived from experiments that focused on the proliferative phase, in which macrophages and tissue-producing cells have colonized the scaffold material. (B) Myofibroblasts from human saphenous vein (red) and PBMC-derived macrophage (green) distribution at the outer side of the electrospun scaffold (grey) at day 3. Scale bar 200 µm. (C) Cross-section of the co-culture construct at day 20 stained for collagen type I (green), collagen type III (red), and DAPI (white). Scale bar 100 µm, *indicates outer side of the construct, corresponding to the flow side. (D) SEM images of decellularized grafts of 8 days macrophage monoculture showing macrophage degradation; scale bar 20 µm. Abbreviations: human saphenous venous cells (HVSC); peripheral blood mononuclear cell (PBMC); 4′,6-diamidino-2-phenylindole (DAPI); scanning electron microscopy (SEM). Panel A was adapted from Wissing and Bonito et al.27; panels B and C were adapted from Van Haaften and Wissing et al.44; and panel D was adapted from Wissing et al.43. Please click here to view a larger version of this figure.

Figure 5: Inflammatory environment in hemodynamically loaded co-culture constructs at 3 days and 20 days. Co-culture of human PBMC-derived macrophages and human myofibroblasts from saphenous veins. (A) Heat map of total cytokine secretion measured in supernatant via multiplex ELISA. (B) Boxplots for a selection of cytokines at day 20, normalized to total DNA content. P-values were calculated using Kruskal-Wallis test with a Dunn’s multiple comparison test; * p < 0.05, ** p < 0.01, *** Abbreviations: tissue inhibitor of metalloproteinase (TIMP), matrix metalloproteinase (MMP), interleukin (IL), monocyte chemoattractant protein 1 (MCP-1), transforming growth factor beta 1 (TGF-β1), connective tissue growth factor (CTGF), tumor necrosis factor alpha (TNF-α), platelet-derived growth factor (PDGF), static (ST), cyclic stretch (CS), shear stress (SS). Panels A and B were adapted from Van Haaften and Wissing et al.44. Please click here to view a larger version of this figure.

Figure 6: Changes in myofibroblast phenotype and markers of matrix growth and remodeling in response to hemodynamic loading in the vascular constructs at day 20. (A) Relative gene expression of myofibroblast-specific phenotypic markers. (B) Cross-sections stained for αSMA (green) and DAPI (blue), scale bar 100 μm. (C) Relative expression of genes related to collagenous matrix, elastic matrix, proteoglycans, and remodeling genes. P-values were calculated using Kruskal-Wallis test with a Dunn’s multiple comparison test; * p < 0.05, ** p < 0.01, *** p < 0.001. Abbreviations: S100 calcium binding protein A4 (S100A4), alpha-smooth muscle actin (αSMA or ACTA2), calponin 1 (CNN1), smoothelin (SMTN), vimentin (VIM), collagen I (COL1A1), elastin (ELN), versican (VCAN), matrix metalloproteinase (MMP), tissue inhibitor of metalloproteinase (TIMP), static (ST), cyclic stretch (CS), shear stress (SS), 4′,6-diamidino-2-phenylindole (DAPI). # measured at or below the detection limit. Panels A, B, and C were adapted from Van Haaften and Wissing et al.44. Please click here to view a larger version of this figure.
Supplementary Figure S1: Protein expression myofibroblast- and macrophage-monocultures subjected to individual and combined hemodynamic loads. (A) Representative confocal images of myofibroblasts, cultured for 10 days with actin fibers (green), nuclei (red), and scaffold (blue), show a clear actin fiber orientation in the loaded samples, when compared to the static samples in which no preferential actin fiber direction can be observed. Scale bar 50 µm. (B) Confocal images of same myofibroblast monoculture stained for collagen (green) and nuclei/scaffold (white). Scale bar 50 µm. (C) Boxplots of protein secretion profiles of statically and dynamically cultured THP1-derived macrophages for 8 days, with calculated M1/M2 ratios based on the cytokine secretion levels of IL-6, TNF-α, MCP-1 (pro-inflammatory) and IL-10, IL-13, MMP-9 (anti-inflammatory). The dot in the MCP-1 graph represents a statistical outlier. (D) ELISA data of the relative protein secretion levels of statically and dynamically cultured macrophages at day 8 compared to the average secretion of pro-inflammatory, anti-inflammatory, growth, and remodeling proteins (protein levels were corrected for the average DNA content per group). The dots and shaded areas indicate, respectively, the 50th and 25th–75th percentiles. Abbreviations: monocyte chemoattractant protein 1 (MCP-1), interleukin (IL), transforming growth factor beta (TGF-β), matrix metalloproteinase (MMP), platelet-derived growth factor (PDGF), connective tissue growth factor (CTGF), tumor necrosis factor alpha (TNF-α), enzyme-linked immunosorbent assay (ELISA).* p < 0.05; ** p < 0.01, *** p < 0.001. Panels A and B were adapted from Van Haaften et al.19. Panels C and D were adapted from Wissing et al.43. Please click here to download this figure.